Program Outline

Monday, October 19, 2020

08:00 – 08:15

08:15 – 08:30

08:30 – 10:30

10:30 – 10:45

10:45 – 12:15

12:15 – 12:45

 

12:45 – 13:45

 

12:45 – 13:45

 

12:45 – 13:45

 

12:45 – 13:45

 

13:45 – 14:00

14:00 – 16:00

16:15 – 17:15

 

20:00 – 21:00

Exhibition and E-Posters Visit

Opening Words

Parallel Sessions

Coffee Break, Exhibition and E-Posters Visit

Plenary 1

Lunch Break, Exhibition and E-Posters Visit

 

Satellite Session: Abbott Laboratories

Structural Heart- tailored therapy for every patient

Satellite Session: Novartis Israel

Dilemmas in CV risk management

Satellite Session: Novo Nordisk

ASCVD & T2D: Bridging the Evidence into Clinical Practice

Satellite Session: Bayer Israel

Diabetes Mellitus – Implications for Patients with Cardiovascular Disease

Coffee Break, Exhibition and E-Posters Visit

Parallel Sessions

Satellite Session: Boehringer Ingelheim Israel LTD

The Future Trajectory for your HF Patient

Focus Groups

Tuesday, October 20, 2020

08:00 – 08:20

08:20 – 08:30

08:30 – 10:30

10:30 – 10:45

10:45 – 12:15

12:15 – 12:45

12:45 – 13:45

 

12:45 – 13:45

 

 

12:45 – 13:45

 

13:45 – 14:00

14:00 – 16:00

16:15 – 17:15

 

16:15 – 17:15

 

18:00

20:00 – 21:00

Exhibition and E-Posters Visit

Opening Words and Updates

Parallel Sessions

Coffee Break, Exhibition and E-Posters Visit

Plenary 2

Lunch Break, Exhibition and E-Posters Visit

Satellite Session: AstraZeneca (Israel)

A New Era in HF and Renal Disease Modification with sglt2i’s

Satellite Session: Sanofi

Is there more to hyper-cholesterolemia management than LDL reduction?

Sub analyses of high risk groups from the Odyssey Outcome trial

Satellite Session: Pfizer Pharmaceuticals Israel

Where are the ATTR-CM patients? How to recognize and diagnose them 

Coffee Break, Exhibition and E-Posters Visit

Parallel Sessions

Satellite Session: Pfizer Pharmaceuticals Israel

How AI meets AF – Innovative Technologies for AF Detection

Satellite Session: Novo Nordisk

Managing the burden of cardiovascular disease: time to focus on obesity care

Annual General Assembly of IHS

Focus Groups